CN Patent

CN114761022B — 药物组合物

Assigned to Senju Pharmaceutical Co Ltd · Expires 2024-02-13 · 2y expired

What this patent protects

本发明以提供保存稳定性优异的药物组合物作为目的。本发明涉及的药物组合物含有0.0005w/v％以上且0.05w/v％以下的葡萄糖、非离子表面活性剂、和烷基二氨基乙基甘氨酸盐酸盐。

USPTO Abstract

本发明以提供保存稳定性优异的药物组合物作为目的。本发明涉及的药物组合物含有0.0005w/v％以上且0.05w/v％以下的葡萄糖、非离子表面活性剂、和烷基二氨基乙基甘氨酸盐酸盐。

Drugs covered by this patent

olopatadine-hydrochloride (OLOPATADINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN114761022B
Jurisdiction: CN
Classification: —
Expires: 2024-02-13
Drug substance claim: No
Drug product claim: No
Assignee: Senju Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.